Results 201 to 210 of about 15,062 (245)
Integrative Multi-Analysis Identifies METTL3-Regulated FGF19 and H6PD as Candidate Targets in Diabetic Cognitive Impairment. [PDF]
Fu J +6 more
europepmc +1 more source
METTL3-driven m<sup>6</sup>A modification of NLRC5 promotes renal fibrosis in chronic kidney disease through Keap1/Nrf2/ARE signaling pathway. [PDF]
Xu M +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Discovery of a PROTAC degrader for METTL3-METTL14 complex
Cell Chemical BiologyN6-methyladenosine (m6A) methylation is the most abundant type of RNA modification that is mainly catalyzed by the METTL3-METTL14 methyltransferase complex. This complex has been linked to multiple cancers and is considered a promising therapeutic target for acute myeloid leukemia (AML).
Qiongyu Shi
exaly +3 more sources
UVB promotes melanogenesis by regulating METTL3
Journal of Cellular Physiology, 2023AbstractUltraviolet (UV) radiation is the primary exogenous inducer of skin pigmentation, although the mechanism has not been fully elucidated. N6‐methyladenosine (m6A) modification is one of the key epigenetic form of gene regulation that affects multiple biological processes.
Haoran Guo +10 more
openaire +2 more sources
The Role of METTL3 in the Progression of Cardiac Fibrosis
Current Topics in Medicinal Chemistry, 2023Abstract: Cardiac fibrosis is known as the expansion of the cardiac interstitium through excessive deposition of extracellular matrix proteins; this process is performed by a multifunctional cell known as the cardiac fibroblast. After the myocardial injury, these cells are activated as a repair program, increase, and switch to a contractile phenotype,
Samir Bolívar +5 more
openaire +2 more sources
Biological Chemistry, 2020
Abstract N 6-methyladenosine (m6A) is the most abundant modification in mRNA. The core of the human N 6-methyltransferase complex (MTC) is formed by a heterodimer consisting of METTL3 and METTL14, which specifically catalyzes m6A formation within an RRACH sequence context.
Nathalie Meiser +2 more
openaire +2 more sources
Abstract N 6-methyladenosine (m6A) is the most abundant modification in mRNA. The core of the human N 6-methyltransferase complex (MTC) is formed by a heterodimer consisting of METTL3 and METTL14, which specifically catalyzes m6A formation within an RRACH sequence context.
Nathalie Meiser +2 more
openaire +2 more sources
METTL3: a multifunctional regulator in diseases
Molecular and Cellular BiochemistryN6-methyladenosine (m6A) methylation is the most prevalent and abundant internal modification of mRNAs and is catalyzed by the methyltransferase complex. Methyltransferase-like 3 (METTL3), the best-known m6A methyltransferase, has been confirmed to function as a multifunctional regulator in the reversible epitranscriptome modulation of m6A modification
Na, Li +4 more
openaire +2 more sources
METTL3 is required for maintaining β-cell function
Metabolism, 2021N6-methyladenosine (m6A) mRNA methylation has been shown to regulate obesity and type 2 diabetes. However, whether METTL3, the key methyltransferase for m6A mRNA methylation, regulates β-cell failure in diabetes has not been fully explored. Here, we show that METTL3 is downregulated under the inflammatory and oxidative stress conditions, and islet β ...
Xinzhi, Li +4 more
openaire +2 more sources
Lung
m6A RNA methylation is a critical epigenetic modification involved in the pathogenesis of pulmonary arterial hypertension (PAH). While macrophage-mediated inflammation plays a central role in PAH, the specific contributions of m6A regulators within macrophages are not yet fully understood.
Chunfeng, He +8 more
openaire +2 more sources
m6A RNA methylation is a critical epigenetic modification involved in the pathogenesis of pulmonary arterial hypertension (PAH). While macrophage-mediated inflammation plays a central role in PAH, the specific contributions of m6A regulators within macrophages are not yet fully understood.
Chunfeng, He +8 more
openaire +2 more sources

